Dietary total antioxidant capacity is inversely associated with the odds of non-alcoholic fatty liver disease in people with type-2 diabetes

被引:2
|
作者
Salavatizadeh, Marieh [1 ,2 ]
Soltanieh, Samira [1 ,2 ]
Poustchi, Hossein [3 ]
Yari, Zahra [4 ]
Shabanpur, Maryam [5 ]
Mansour, Asieh [6 ]
Khamseh, Mohammad E. [2 ]
Alaei-Shahmiri, Fariba [2 ]
Hekmatdoost, Azita [1 ]
机构
[1] Shahid Beheshti Univ Med Sci, Fac Nutr & Food Technol, Dept Clin Nutr & Dietet, Tehran, Iran
[2] Iran Univ Med Sci, Inst Endocrinol & Metab, Endocrine Res Ctr, Tehran, Iran
[3] Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Inst, Liver & Pancreatobiliary Dis Res Ctr, Tehran, Iran
[4] Shahid Beheshti Univ Med Sci, Natl Nutr & Food Technol Res Inst, Fac Nutr Sci & Food Technol, Dept Nutr Res, Tehran, Iran
[5] Jahrom Univ Med Sci, Dept Nutr, Jahrom, Iran
[6] Univ Tehran Med Sci, Endocrinol & Metab Clin Sci Inst, Endocrinol & Metab Res Ctr, Tehran, Iran
来源
FRONTIERS IN NUTRITION | 2022年 / 9卷
关键词
NAFLD; diabetes; diet; DTAC; antioxidant; CARDIOVASCULAR RISK-FACTORS; INSULIN-RESISTANCE; DASH DIET; GLUCOSE; SENSITIVITY; PREVALENCE; MELLITUS;
D O I
10.3389/fnut.2022.1037851
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
BackgroundThis study was conducted to evaluate possible associations between Dietary Total Antioxidant Capacity (DTAC) and odds of non-alcoholic fatty liver disease (NAFLD) in people with type-2 diabetes mellitus (T2DM). Materials and methodsWe recruited two hundred people with T2DM, and evaluated their liver steatosis using Fibroscan. Dietary intakes of participants were assessed using a validated food frequency questionnaire. DTAC was computed via ferric reducing antioxidant power (FRAP). ResultsIn the crude model, no statistically significant association was found between DTAC and the odds of NAFLD in people with diabetes. However, after adjustment for potential confounders including age, gender, diabetes duration, smoking status, physical activity, BMI, waist circumference, and energy, the most reduced adjusted OR was indicated for the third tertile vs. the first one (OR: 0.28, 95% CI: 0.09-0.81, P = 0.02), meaning that diabetic patients in the third tertile of DTAC had 72% decreased risk of NAFLD in comparison to those in the first one. The relationship was remained significant after additional adjustment for HOMA-IR, HbA1c, serum Triglyceride (TG), and low-density lipoprotein-cholesterol (LDL) levels (OR: 0.29, 95% CI: 0.09-0.93, P = 0.03). Importantly, a dose-response pattern was demonstrated for DTAC and risk of NAFLD (P = 0.04). ConclusionHigher DTAC was related with a decreased risk of NAFLD in individuals with diabetes.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Hepatic steatosis and non-alcoholic fatty liver disease are not associated with decline in renal function in people with Type 2 diabetes
    Jenks, S. J.
    Conway, B. R.
    Hor, T. J.
    Williamson, R. M.
    McLachlan, S.
    Robertson, C.
    Morling, J. R.
    Strachan, M. W. J.
    Price, J. F.
    [J]. DIABETIC MEDICINE, 2014, 31 (09) : 1039 - 1046
  • [22] Comparisons of dietary intake in Japanese with non-alcoholic fatty liver disease and type 2 diabetes mellitus
    Kobayashi, Yukiko
    Tatsumi, Hina
    Hattori, Mikako
    Sugiyama, Hiroki
    Wada, Sayori
    Kuwahata, Masashi
    Tanaka, Saiyu
    Kanemasa, Kazuyuki
    Sumida, Yoshio
    Naito, Yuji
    Fukui, Michiaki
    Kido, Yasuhiro
    [J]. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2016, 59 (03) : 215 - 219
  • [23] Non-alcoholic fatty liver disease and type 1 diabetes
    Moreno-Ruiz, I.
    Martin-Timon, I.
    Modamio-Molina, J.
    Bacete-Cebrian, S.
    Zubillaga-Gomez, M.
    Zeng, L.
    Meizoso-Pita, O.
    Trivino-Yannuzzi, V.
    Huguet-Moreno, I.
    Llavero-Valero, M.
    Lara-Moreno, C.
    Sevillano-Collantes, C.
    [J]. DIABETOLOGIA, 2022, 65 (SUPPL 1) : S408 - S408
  • [24] Development of Non-Alcoholic Fatty Liver Disease in type-2 Diabetics and Factors Associated With Its Development
    Singh, Amandeep
    Gosai, Falgun
    Lopez, Rocio
    Alkhouri, Naim
    Kirby, Donald
    McCullough, Arthur
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S455 - S455
  • [25] Non-alcoholic fatty liver disease and type 2 diabetes Management and treatment
    Puetzer, Jennifer
    Kahl, Sabine
    [J]. DIABETOLOGE, 2020, 16 (06): : 574 - 583
  • [26] The prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus
    Heyens, Leen
    Robaeys, Geert
    Bielen, Rob
    Kockaerts, Yves
    Busschots, Dana
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 : S412 - S413
  • [27] Non-alcoholic fatty liver disease in type 2 diabetes - A specific entity?
    Schroeder, Benjamin
    Kahl, Sabine
    Roden, Michael
    [J]. LIVER INTERNATIONAL, 2021, 41 : 105 - 111
  • [28] Non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus
    Resuli, B.
    Agaci, F.
    Kraja, B.
    Sema, K.
    Dhigoi, N.
    Kapia, M.
    Burda, I.
    [J]. DIABETOLOGIA, 2010, 53
  • [29] TIME ABOVE RANGE IS ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE IN ADULT PEOPLE WITH TYPE 1 DIABETES
    Belde, S.
    Aernouts, C.
    Lambrechts, J.
    Mertens, J.
    Ledeganck, K.
    Francque, S.
    De Block, C.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A204 - A205
  • [30] Type 2 diabetes originated from non-alcoholic fatty liver disease
    Xuelian Xiong
    Xiaoying Li
    [J]. Life Metabolism, 2023, 2 (01) - 12